Orca Biosystems, Inc.

This program provides access to Orca-T cell therapy for patients with blood cancers when the standard commercial product doesn't meet quality specifications. It's designed for patients who were already scheduled to receive Orca-T but whose manufactured product didn't pass all rel…

This trial is comparing a new, engineered cell transplant called Orca-T against the standard transplant for people with advanced blood cancers like leukemia. The goal is to see if Orca-T can better control the cancer while reducing a serious complication called graft-versus-host …